Keros Therapeutics, Inc. Earnings Per Share (Basic)
Keros Therapeutics, Inc. (KROS) reported Earnings Per Share (Basic) of -$1.45 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-03
- Keros Therapeutics, Inc. earnings per share, basic for the quarter ending 2026-06-30 was -$1.45.
- Keros Therapeutics, Inc. earnings per share, basic for the quarter ending 2026-03-31 was -$1.21, a 133.06% decline year-over-year.
- Keros Therapeutics, Inc. earnings per share, basic for the quarter ending 2025-12-31 was -$0.87.
- Keros Therapeutics, Inc. earnings per share, basic for the quarter ending 2025-09-30 was -$0.18.
- Keros Therapeutics, Inc. earnings per share, basic for fiscal 2025 was $2.34.
- Keros Therapeutics, Inc. earnings per share, basic for fiscal 2024 was -$5.00.
- Keros Therapeutics, Inc. earnings per share, basic for fiscal 2023 was -$5.20.
- Keros Therapeutics, Inc. earnings per share, basic for fiscal 2022 was -$4.15.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$1.45 10-Q · filed 2026-08-03 | -$2.66 10-Q · filed 2026-08-03 | -$3.42 derived: net income ÷ weighted average shares · filed 2026-08-03 | -$3.10 derived: net income ÷ weighted average shares · filed 2026-08-03 |
| 2026-03-31 | -$1.21 10-Q · filed 2026-05-14 | -$2.02 derived: net income ÷ weighted average shares · filed 2026-05-14 | -$1.87 derived: net income ÷ weighted average shares · filed 2026-05-14 | -$2.66 derived: net income ÷ weighted average shares · filed 2026-08-03 |
| 2025-12-31 | -$0.87 derived: net income ÷ weighted average shares · filed 2026-03-04 | -$0.91 derived: net income ÷ weighted average shares · filed 2026-03-04 | -$1.70 derived: net income ÷ weighted average shares · filed 2026-08-03 | $2.34 10-K · filed 2026-03-04 |
| 2025-09-30 | -$0.18 10-Q · filed 2025-11-05 | -$0.93 derived: net income ÷ weighted average shares · filed 2026-08-03 | $2.72 10-Q · filed 2025-11-05 | $1.59 derived: net income ÷ weighted average shares · filed 2026-08-03 |
| 2025-06-30 | -$0.76 10-Q · filed 2026-08-03 | $2.90 10-Q · filed 2026-08-03 | $1.77 derived: net income ÷ weighted average shares · filed 2026-08-03 | $0.47 derived: net income ÷ weighted average shares · filed 2026-08-03 |
| 2025-03-31 | $3.66 10-Q · filed 2026-05-14 | $2.53 derived: net income ÷ weighted average shares · filed 2026-05-14 | $1.25 derived: net income ÷ weighted average shares · filed 2026-05-14 | $0.11 derived: net income ÷ weighted average shares · filed 2026-05-14 |
| 2024-12-31 | -$1.14 derived: net income ÷ weighted average shares · filed 2026-03-04 | -$2.54 derived: net income ÷ weighted average shares · filed 2026-03-04 | -$3.79 derived: net income ÷ weighted average shares · filed 2026-03-04 | -$5.00 10-K · filed 2026-03-04 |
| 2024-09-30 | -$1.41 10-Q · filed 2025-11-05 | -$2.67 derived: net income ÷ weighted average shares · filed 2025-11-05 | -$3.88 10-Q · filed 2025-11-05 | -$5.21 derived: net income ÷ weighted average shares · filed 2025-11-05 |
| 2024-06-30 | -$1.25 10-Q · filed 2025-08-06 | -$2.46 10-Q · filed 2025-08-06 | -$3.79 derived: net income ÷ weighted average shares · filed 2025-08-06 | -$5.11 derived: net income ÷ weighted average shares · filed 2025-08-06 |
| 2024-03-31 | -$1.21 10-Q · filed 2025-05-06 | -$2.53 derived: net income ÷ weighted average shares · filed 2025-05-06 | -$3.86 derived: net income ÷ weighted average shares · filed 2025-05-06 | -$5.13 derived: net income ÷ weighted average shares · filed 2025-05-06 |
| 2023-12-31 | -$1.34 derived: net income ÷ weighted average shares · filed 2025-02-26 | -$2.66 derived: net income ÷ weighted average shares · filed 2025-02-26 | -$3.93 derived: net income ÷ weighted average shares · filed 2025-02-26 | -$5.20 10-K · filed 2025-02-26 |
| 2023-09-30 | -$1.33 10-Q · filed 2024-11-06 | -$2.60 derived: net income ÷ weighted average shares · filed 2024-11-06 | -$3.86 10-Q · filed 2024-11-06 | -$4.96 derived: net income ÷ weighted average shares · filed 2025-02-26 |
| 2023-06-30 | -$1.27 10-Q · filed 2024-08-07 | -$2.53 10-Q · filed 2024-08-07 | -$3.62 derived: net income ÷ weighted average shares · filed 2025-02-26 | -$4.57 derived: net income ÷ weighted average shares · filed 2025-02-26 |
| 2023-03-31 | -$1.26 10-Q · filed 2024-05-08 | -$2.35 derived: net income ÷ weighted average shares · filed 2025-02-26 | -$3.29 derived: net income ÷ weighted average shares · filed 2025-02-26 | -$4.42 derived: net income ÷ weighted average shares · filed 2025-02-26 |
| 2022-12-31 | -$1.09 derived: net income ÷ weighted average shares · filed 2025-02-26 | -$2.01 derived: net income ÷ weighted average shares · filed 2025-02-26 | -$3.14 derived: net income ÷ weighted average shares · filed 2025-02-26 | -$4.15 10-K · filed 2025-02-26 |
| 2022-09-30 | -$0.92 10-Q · filed 2023-11-06 | -$2.05 derived: net income ÷ weighted average shares · filed 2023-11-06 | -$3.05 10-Q · filed 2023-11-06 | -$3.38 derived: net income ÷ weighted average shares · filed 2024-02-28 |
| 2022-06-30 | -$1.13 10-Q · filed 2023-08-07 | -$2.14 10-Q · filed 2023-08-07 | -$2.45 derived: net income ÷ weighted average shares · filed 2024-02-28 | -$3.32 derived: net income ÷ weighted average shares · filed 2024-02-28 |
| 2022-03-31 | -$1.01 10-Q · filed 2023-05-04 | -$1.31 derived: net income ÷ weighted average shares · filed 2024-02-28 | -$2.18 derived: net income ÷ weighted average shares · filed 2024-02-28 | -$2.85 derived: net income ÷ weighted average shares · filed 2024-02-28 |
| 2021-12-31 | -$0.30 derived: net income ÷ weighted average shares · filed 2024-02-28 | -$1.16 derived: net income ÷ weighted average shares · filed 2024-02-28 | -$1.83 derived: net income ÷ weighted average shares · filed 2024-02-28 | -$2.52 10-K · filed 2024-02-28 |
| 2021-09-30 | -$0.87 10-Q · filed 2022-11-03 | -$1.54 derived: net income ÷ weighted average shares · filed 2022-11-03 | -$2.22 10-Q · filed 2022-11-03 | -$2.69 derived: net income ÷ weighted average shares · filed 2022-11-03 |
| 2021-06-30 | -$0.67 10-Q · filed 2022-08-04 | -$1.35 10-Q · filed 2022-08-04 | -$1.81 derived: net income ÷ weighted average shares · filed 2022-08-04 | -$2.41 derived: net income ÷ weighted average shares · filed 2022-08-04 |
| 2021-03-31 | -$0.68 10-Q · filed 2022-05-05 | -$1.14 derived: net income ÷ weighted average shares · filed 2022-05-05 | -$1.73 derived: net income ÷ weighted average shares · filed 2022-05-05 | -$2.35 derived: net income ÷ weighted average shares · filed 2022-05-05 |
| 2020-12-31 | -$0.45 derived: net income ÷ weighted average shares · filed 2022-03-09 | -$1.04 derived: net income ÷ weighted average shares · filed 2022-03-09 | -$1.65 derived: net income ÷ weighted average shares · filed 2022-03-09 | -$2.93 10-K · filed 2022-03-09 |
| 2020-09-30 | -$0.60 10-Q · filed 2021-11-04 | -$1.22 derived: net income ÷ weighted average shares · filed 2021-11-04 | -$2.65 10-Q · filed 2021-11-04 | |
| 2020-06-30 | -$0.62 10-Q · filed 2021-08-05 | -$2.35 10-Q · filed 2021-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |